Clinical trial
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
NCT00122356 · Barwon Health, Other · Completed
Key facts
| NCT number | NCT00122356 |
|---|---|
| Title | Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment |
| Official title | Maintaining Skeletal Health in Postmenopausal Women With Surgically Resected Stage I-IIIa Hormone-receptor Positive Breast Cancer Who Are Receiving Anastrozole, Through the Use of Alendronate as Determined by the Osteoporosis Australia Bone Maintenance Algorithm |
| Acronym | BATMAN |
| Lead sponsor | Barwon Health, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Alendronate sodium |
| Enrollment | 303 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jul 22, 2005 |
| Last update posted | Mar 13, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: